$4.47
7.45% today
NYSE, Apr 04, 09:17 pm CET
ISIN
US29089Q1058
Symbol
EBS
Sector
Industry

Emergent Biosolutions Inc Stock price

$4.83
-2.00 29.28% 1M
-4.11 45.97% 6M
-4.73 49.48% YTD
+2.57 113.72% 1Y
-38.38 88.82% 3Y
-52.83 91.62% 5Y
-22.86 82.56% 10Y
NYSE, Closing price Thu, Apr 03 2025
-0.34 6.58%
ISIN
US29089Q1058
Symbol
EBS
Sector
Industry

Key metrics

Market capitalization $262.45m
Enterprise Value $832.95m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 23.27
EV/Sales (TTM) EV/Sales 0.80
P/S ratio (TTM) P/S ratio 0.25
P/B ratio (TTM) P/B ratio 0.54
Revenue growth (TTM) Revenue growth -0.62%
Revenue (TTM) Revenue $1.04b
EBIT (operating result TTM) EBIT $-58.40m
Free Cash Flow (TTM) Free Cash Flow $35.80m
Cash position $105.60m
EPS (TTM) EPS $-3.72
P/E forward negative
P/S forward 0.32
EV/Sales forward 1.02
Short interest 15.58%
Show more

Is Emergent Biosolutions Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Emergent Biosolutions Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Emergent Biosolutions Inc forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Emergent Biosolutions Inc forecast:

Buy
100%

Financial data from Emergent Biosolutions Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,044 1,044
1% 1%
100%
- Direct Costs 739 739
3% 3%
71%
305 305
6% 6%
29%
- Selling and Administrative Expenses 187 187
19% 19%
18%
- Research and Development Expense 65 65
40% 40%
6%
53 53
202% 202%
5%
- Depreciation and Amortization 111 111
12% 12%
11%
EBIT (Operating Income) EBIT -58 -58
67% 67%
-6%
Net Profit -191 -191
75% 75%
-18%

In millions USD.

Don't miss a Thing! We will send you all news about Emergent Biosolutions Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Emergent Biosolutions Inc Stock News

Neutral
GlobeNewsWire
4 days ago
GAITHERSBURG, Md., March 31, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that its Board of Directors has authorized the repurchase of up to $50 million of the company's common stock on or before March 27, 2026.
Neutral
GlobeNewsWire
15 days ago
GAITHERSBURG, Md., March 20, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS), a leading public health company that delivers protective and life-saving solutions to communities across the world, today announced that its Compensation Committee has granted an equity award to a newly hired employee under its 2023 Inducement Plan (the "Inducement Plan").
Neutral
GlobeNewsWire
15 days ago
Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in Canada Emergent BioSolutions will lead commercial launch efforts to increase access to intranasal naloxone and combat opioid overdose poisonings in Canada
More Emergent Biosolutions Inc News

Company Profile

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. The firm's products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Head office United States
CEO Joseph Papa
Employees 900
Founded 1998
Website www.emergentbiosolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today